Medications for Severe Combined Immunodeficiency
7 results
Asceniv (human immunoglobulin g)
(HUMAN IMMUNOGLOBULIN G)ADMA Biologics, Inc.
Usage: ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents aged 12 to 17. This includes conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Bivigam (immune globulin intravenous (human) 10%)
(Immune Globulin Intravenous (Human) 10%)ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency in adults and children aged 2 years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Cutaquig (immunoglobulin g)
(immunoglobulin G)Pfizer Laboratories Div Pfizer Inc
Usage: CUTAQUIG is indicated for replacement therapy in adults and pediatric patients aged 2 and older with primary humoral immunodeficiency (PI), including conditions like common variable immunodeficiency, X-linked agammaglobulinemia, and severe combined immunodeficiencies.
Cuvitru (immune globulin subcutaneous (human))
(Immune Globulin Subcutaneous (Human))Takeda Pharmaceuticals America, Inc.
Usage: CUVITRU is indicated for replacement therapy in primary humoral immunodeficiency in patients aged two years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Flebogamma (immune globulin (human))
(Immune Globulin (Human))GRIFOLS USA, LLC
Usage: Flebogamma 5% DIF is indicated for the treatment of primary immunodeficiency in adults and pediatric patients aged 2 years and older, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.
Xembify (immune globulin subcutaneous, human-klhw)
(immune globulin subcutaneous, human-klhw)GRIFOLS USA, LLC
Usage: XEMBIFY® is a 20% human immune globulin solution for subcutaneous injection, indicated for treating primary humoral immunodeficiency (PI) in patients aged 2 and older, including conditions such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Yimmugo (immune globulin intravenous, human - dira)
(immune globulin intravenous, human - dira)Biotest AG
Usage: YIMMUGO is indicated for treating primary humoral immunodeficiency (PI) in patients aged 2 and older, including conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia (XLA), Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).